290298-12-3 Usage
Description
(2R,3S,4S,5R,6S)-2-(acetoxymethyl)-6-(4-(hydroxymethyl)-2-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate is a complex organic molecule characterized by a tetrahydro-2H-pyran core with multiple acetate groups. It features a nitrophenyl group with a hydroxymethyl side chain, along with several acetoxymethyl and triacetate groups. This intricate and diversified structure suggests that it may possess a range of functional properties, making it a candidate for various applications in pharmaceutical, chemical, or biological fields.
Uses
Used in Pharmaceutical Industry:
(2R,3S,4S,5R,6S)-2-(acetoxymethyl)-6-(4-(hydroxymethyl)-2-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate is used as a potential pharmaceutical compound for its diverse functional groups and complex structure, which may contribute to its efficacy in treating various medical conditions.
Used in Chemical Industry:
In the chemical industry, (2R,3S,4S,5R,6S)-2-(acetoxymethyl)-6-(4-(hydroxymethyl)-2-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate may serve as a key intermediate in the synthesis of other complex organic molecules or as a component in the development of new materials with specific properties.
Used in Biological Research:
(2R,3S,4S,5R,6S)-2-(acetoxymethyl)-6-(4-(hydroxymethyl)-2-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate is used as a research tool in biological studies to explore its interactions with biological systems, potentially leading to new insights into its mechanisms of action and applications in medicine or biotechnology.
Check Digit Verification of cas no
The CAS Registry Mumber 290298-12-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,0,2,9 and 8 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 290298-12:
(8*2)+(7*9)+(6*0)+(5*2)+(4*9)+(3*8)+(2*1)+(1*2)=153
153 % 10 = 3
So 290298-12-3 is a valid CAS Registry Number.
290298-12-3Relevant articles and documents
Real-Time Multi-Photon Tracking and Bioimaging of Glycosylated Theranostic Prodrugs upon Specific Enzyme Triggered Release
Calatrava-Pérez, Elena,Elmes, Robert B. P.,Gunnlaugsson, Thorfinnur,Lynch, Dylan M.,Marchetti, Luke A.,McManus, Gavin J.,Scanlan, Eoin M.,Williams, D. Clive
, (2021/12/09)
Real-time tracking of prodrug uptake, delivery and activation in vivo represents a major challenge for prodrug development. Herein, we demonstrate the use of novel glycosylated theranostics of the cancer pharmacophore Amonafide in highly-selective, enzyma
Self-Immolative Activation of β-Galactosidase-Responsive Probes for In Vivo MR Imaging in Mouse Models
Lilley, Laura M.,Kamper, Sarah,Caldwell, Michael,Chia, Zer Keen,Ballweg, David,Vistain, Luke,Krimmel, Jeffrey,Mills, Teresa Anne,MacRenaris, Keith,Lee, Paul,Waters, Emily Alexandria,Meade, Thomas J.
, p. 388 - 394 (2019/11/28)
Our lab has developed a new series of self-immolative MR agents for the rapid detection of enzyme activity in mouse models expressing β-galactosidase (β-gal). We investigated two molecular architectures to create agents that detect β-gal activity by modul
FLUOROGENIC GLYCOSIDASE SUBSTRATE AND ASSOCIATED DETECTION METHOD
-
, (2020/01/22)
The invention relates to novel glycosidase substrates of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R′9, V, X, Y and Z are as defined in claim 1, and a method for detecting the presence of a catalytically active glycosidase by means of one of said substrates.
